<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00962676</url>
  </required_header>
  <id_info>
    <org_study_id>4-2009-0129</org_study_id>
    <nct_id>NCT00962676</nct_id>
  </id_info>
  <brief_title>Diagnostic Usefulness of Interferon Gamma Release Assay for Active Tuberculosis in Immunocompromised Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <brief_summary>
    <textblock>
      For diagnosis of active tuberculosis, interferon-γ release assay based mycobacterium&#xD;
      tuberculosis specific antigen may show higher sensitivity than tuberculin skin test in&#xD;
      immunocompromised patients. Therefore, interferon-γ release assay have a role as a rapid&#xD;
      diagnostic adjunctive methods for active tuberculosis in immunocompromised patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">140</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>immunocompromised group</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-immunocompromised group</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        suspicious of tuberculosis, immunocompromised patients such cancer patients on&#xD;
        chemotherapy, transplantation patients, patients with immunosuppressant&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient suspicious of active tuberculosis with immunocompromised condition&#xD;
&#xD;
          -  Immunocompromised condition patients with&#xD;
&#xD;
               1. solid cancer with chemotherapy&#xD;
&#xD;
               2. hematologic malignancy&#xD;
&#xD;
               3. organ transplantation&#xD;
&#xD;
               4. immunosuppressant&#xD;
&#xD;
               5. ESRD on renal replacement therapy&#xD;
&#xD;
               6. diabetes&#xD;
&#xD;
               7. advanced liver cirrhosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with&#xD;
&#xD;
               1. less than 20 years&#xD;
&#xD;
               2. who don't agree the participation of study&#xD;
&#xD;
               3. hypersensitivity history to tuberculin&#xD;
&#xD;
               4. pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yonsei Univ.</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <study_first_submitted>August 19, 2009</study_first_submitted>
  <study_first_submitted_qc>August 19, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2009</study_first_posted>
  <last_update_submitted>January 31, 2012</last_update_submitted>
  <last_update_submitted_qc>January 31, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>suspicious of tuberculosis</keyword>
  <keyword>immunocompromised patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

